Publication | Closed Access

A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateMedicineOral IsoliquiritigeninNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyTumor MicroenvironmentTumor BiologyTumor-targeted Delivery